Cargando…
Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access
Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participant...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252367/ https://www.ncbi.nlm.nih.gov/pubmed/32450757 http://dx.doi.org/10.1177/2150132720923938 |
_version_ | 1783539146656055296 |
---|---|
author | Ally, Muhamad Z. Persaud, Nav Umali, Norman |
author_facet | Ally, Muhamad Z. Persaud, Nav Umali, Norman |
author_sort | Ally, Muhamad Z. |
collection | PubMed |
description | Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participants. Methods: We conducted thematic analysis of comments made by participants and prescribers, and chart stimulated recalls with the pharmacist involved with the novel pharmacy model implemented in a clinical trial. Results: Major themes from participant’s comments related to the ease of obtaining information about medications from the pharmacy and satisfaction with the delivery. Prescribers felt that this model facilitated collaboration with the pharmacist and welcomed suggestions regarding therapeutic medication changes. Major themes from the pharmacist’s chart stimulated recalls were that access to participants’ EHRs allowed for improved drug therapy management and participant experience, and this pharmacy model increased participant’s access to pharmacy services. Discussion: According to the pharmacist and prescribers, this pharmacy model facilitated their collaboration in prescribing appropriate medications and participants were generally satisfied with the delivery of medications. Conclusion: Participants and prescribers were generally supportive of a pharmacy model that combined allowing the pharmacist access to participants’ EHR and medication mailing. This allowed the pharmacist more opportunities for drug therapy management and collaboration with prescribers. It also improved the participant’s access to pharmacy services, although those services were not always fully utilized. |
format | Online Article Text |
id | pubmed-7252367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-72523672020-06-08 Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access Ally, Muhamad Z. Persaud, Nav Umali, Norman J Prim Care Community Health Original Research Background: In Canada, pharmacists accessing electronic health records (EHR) and mailing medications to patients are relatively uncommon. We evaluated a pharmacy model implemented in a clinical trial that combined allowing the pharmacist access to patients’ EHR and mailing medications to participants. Methods: We conducted thematic analysis of comments made by participants and prescribers, and chart stimulated recalls with the pharmacist involved with the novel pharmacy model implemented in a clinical trial. Results: Major themes from participant’s comments related to the ease of obtaining information about medications from the pharmacy and satisfaction with the delivery. Prescribers felt that this model facilitated collaboration with the pharmacist and welcomed suggestions regarding therapeutic medication changes. Major themes from the pharmacist’s chart stimulated recalls were that access to participants’ EHRs allowed for improved drug therapy management and participant experience, and this pharmacy model increased participant’s access to pharmacy services. Discussion: According to the pharmacist and prescribers, this pharmacy model facilitated their collaboration in prescribing appropriate medications and participants were generally satisfied with the delivery of medications. Conclusion: Participants and prescribers were generally supportive of a pharmacy model that combined allowing the pharmacist access to participants’ EHR and medication mailing. This allowed the pharmacist more opportunities for drug therapy management and collaboration with prescribers. It also improved the participant’s access to pharmacy services, although those services were not always fully utilized. SAGE Publications 2020-05-26 /pmc/articles/PMC7252367/ /pubmed/32450757 http://dx.doi.org/10.1177/2150132720923938 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Ally, Muhamad Z. Persaud, Nav Umali, Norman Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title | Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title_full | Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title_fullStr | Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title_full_unstemmed | Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title_short | Evaluation of Pharmacy Model in a Trial of Free Essential Medicine Access |
title_sort | evaluation of pharmacy model in a trial of free essential medicine access |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252367/ https://www.ncbi.nlm.nih.gov/pubmed/32450757 http://dx.doi.org/10.1177/2150132720923938 |
work_keys_str_mv | AT allymuhamadz evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess AT persaudnav evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess AT umalinorman evaluationofpharmacymodelinatrialoffreeessentialmedicineaccess |